Group One Trading
INFI

Group One Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Group One Trading’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,600
Closed -$8.34K – 8573
2023
Q2 		$8.34K Sell
39,600
-1,000
-2% -$174 ﹤0.01% 6480
2023
Q1 		$6.5K Sell
40,600
-100
-0.2% -$44 ﹤0.01% 6169
2022
Q4 		$22.6K Sell
40,700
-34,600
-46% -$29.4K ﹤0.01% 5525
2022
Q3 		$90K Buy
75,300
+3,600
+5% +$3.88K ﹤0.01% 4877
2022
Q2 		$45K Sell
71,700
-40,600
-36% -$31.2K ﹤0.01% 5665
2022
Q1 		$128K Sell
112,300
-39,300
-26% -$47K ﹤0.01% 5259
2021
Q4 		$341K Sell
151,600
-64,500
-30% -$162K ﹤0.01% 4541
2021
Q3 		$739K Buy
216,100
+112,900
+109% +$348K ﹤0.01% 3748
2021
Q2 		$309K Sell
103,200
-56,000
-35% -$177K ﹤0.01% 4761
2021
Q1 		$514K Buy
159,200
+144,500
+983% +$482K ﹤0.01% 4000
2020
Q4 		$31K Sell
14,700
-21,200
-59% -$35K ﹤0.01% 5284
2020
Q3 		$42K Buy
35,900
+31,800
+776% +$32.7K ﹤0.01% 4754
2020
Q2 		$4K Buy
4,100
+100
+3% +$95 ﹤0.01% 5457
2020
Q1 		$3K Sell
4,000
-31,300
-89% -$36.3K ﹤0.01% 4920
2019
Q4 		$34K Buy
35,300
+21,900
+163% +$24K ﹤0.01% 4174
2019
Q3 		$14K Sell
13,400
-11,300
-46% -$15.4K ﹤0.01% 4494
2019
Q2 		$44K Sell
24,700
-6,800
-22% -$10.9K ﹤0.01% 3842
2019
Q1 		$59K Buy
31,500
+200
+0.6% +$293 ﹤0.01% 3480
2018
Q4 		$37K Sell
31,300
-31,400
-50% -$56.5K ﹤0.01% 3715
2018
Q3 		$170K Sell
62,700
-57,500
-48% -$119K ﹤0.01% 3130
2018
Q2 		$230K Buy
120,200
+55,600
+86% +$112K ﹤0.01% 2938
2018
Q1 		$136K Sell
64,600
-36,300
-36% -$77.8K ﹤0.01% 3054
2017
Q4 		$205K Buy
100,900
+93,900
+1,341% +$195K ﹤0.01% 2913
2017
Q3 		$9K Sell
7,000
-99,900
-93% -$124K ﹤0.01% 4330
2017
Q2 		$168K Buy
106,900
+24,800
+30% +$47.8K ﹤0.01% 2771
2017
Q1 		$265K Buy
82,100
+79,600
+3,184% +$196K ﹤0.01% 2322
2016
Q4 		$3K Sell
2,500
-13,200
-84% -$17.2K ﹤0.01% 4212
2016
Q3 		$24K Buy
+15,700
New +$24.1K ﹤0.01% 3718
2016
Q2 		– Sell
-3,300
Closed -$17K – 5029
2016
Q1 		$17K Buy
3,300
+1,900
+136% +$11.6K ﹤0.01% 3832
2015
Q4 		$11K Sell
1,400
-36,500
-96% -$314K ﹤0.01% 4152
2015
Q3 		$320K Buy
37,900
+35,200
+1,304% +$325K ﹤0.01% 2142
2015
Q2 		$30K Sell
2,700
-7,000
-72% -$89.8K ﹤0.01% 3839
2015
Q1 		$136K Sell
9,700
-50,300
-84% -$769K ﹤0.01% 2672
2014
Q4 		$1.01M Sell
60,000
-32,700
-35% -$476K 0.02% 1068
2014
Q3 		$1.24M Buy
92,700
+22,000
+31% +$262K 0.02% 954
2014
Q2 		$901K Buy
70,700
+11,900
+20% +$124K 0.01% 1213
2014
Q1 		$699K Sell
58,800
-63,400
-52% -$851K 0.01% 1375
2013
Q4 		$1.69M Buy
122,200
+45,000
+58% +$636K 0.03% 740
2013
Q3 		$1.35M Sell
77,200
-109,700
-59% -$2.1M 0.03% 791
2013
Q2 		$3.04M Buy
+186,900
New +$5.78M 0.07% 260

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Group One Trading's INFI Position: Q3 2023 in Review

Group One Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 14,150 shares — an estimated $2.98K sold.

Group One Trading first reported a position in INFI in Q2 2013 and held it in 36 quarters. The position peaked at $3.04M in Q4 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Group One Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 14,150 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.98K.
  • Group One Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 36 quarters.
  • Group One Trading's Infinity Pharmaceuticals, Inc. position peaked at $3.04M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.